💊 Enoxaparin (Enoxaparin Sodium)
Enoxaparin sodium is a subcutaneously injected low molecular weight heparin with antithrombotic properties. It is used to prevent deep vein thrombosis, to treat acute DVT, and in certain acute heart conditions. It must be used under medical supervision because it can increase the risk of bleeding.
In Arabic: إينوكسابارين الصوديوم
✅ What it is used for
- Prophylaxis of deep vein thrombosis (DVT) in patients undergoing abdominal surgery, hip replacement surgery, or knee replacement surgery
- Prophylaxis of DVT in medical patients with severely restricted mobility during acute illness
- Inpatient treatment of acute DVT with or without pulmonary embolism (with warfarin)
- Outpatient treatment of acute DVT without pulmonary embolism (with warfarin)
- Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction (with aspirin)
- Treatment of acute ST-segment elevation myocardial infarction (STEMI) managed medically or with subsequent percutaneous coronary intervention (PCI)
🧪 Active ingredient
The active ingredient is enoxaparin sodium, a low molecular weight heparin with antithrombotic properties, meaning it helps prevent blood clots from forming.
🌿 Benefits
- Reduces the risk of deep vein thrombosis after surgery or during reduced mobility
- Helps treat acute deep vein thrombosis
- Reduces ischemic complications of unstable angina and non-Q-wave MI when used with aspirin
- Reduces the rate of recurrent MI or death in STEMI when used with aspirin
📝 How to use
- Given by subcutaneous injection; in STEMI an initial intravenous bolus dose is also given as directed by the doctor
- The dose and duration are set by your doctor or pharmacist based on your condition, weight, and kidney function
- Each prefilled syringe is for single, one-time use only and is preservative-free
- For DVT treatment, warfarin is usually added and enoxaparin is continued until the desired anticoagulant effect is reached
- Follow the injection instructions given by your healthcare team and do not change the dose yourself
💊 Dosage forms
- 100 mg/mL prefilled syringes: 30 mg/0.3 mL and 40 mg/0.4 mL
- 100 mg/mL graduated prefilled syringes: 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg/mL
- 150 mg/mL graduated prefilled syringes: 120 mg/0.8 mL and 150 mg/mL
⚠️ Common side effects
- Bleeding
- Anemia
- Thrombocytopenia (low platelets)
- Elevated serum aminotransferases
- Diarrhea
- Nausea
- Ecchymosis (bruising)
- Fever
- Edema, including peripheral edema
- Dyspnea (shortness of breath)
- Confusion
- Injection site pain
🚨 Serious — seek medical help
- Spinal/epidural hematomas that may cause long-term or permanent paralysis
- Severe bleeding at any site
- Heparin-induced thrombocytopenia (HIT) with or without thrombosis
- Severe allergic reactions (pruritus, urticaria, anaphylactic/anaphylactoid reactions)
⛔ Do not use if
- Active major bleeding
- History of immune-mediated heparin-induced thrombocytopenia (HIT) within the past 100 days or presence of circulating antibodies
- Known hypersensitivity to enoxaparin sodium
- Known hypersensitivity to heparin or pork products
❗ Warnings & precautions
- Boxed warning: epidural or spinal hematomas may occur in patients receiving neuraxial anesthesia or undergoing spinal puncture, and may cause long-term or permanent paralysis
- Risk is higher with indwelling epidural catheters, concomitant drugs affecting hemostasis (such as NSAIDs), traumatic or repeated epidural/spinal punctures, and a history of spinal surgery or spinal deformity
- Patients should be monitored frequently for neurological impairment, and urgent treatment is needed if it occurs
- Evaluate all patients for a bleeding disorder before starting treatment unless urgently needed
- Monitor for signs of bleeding
- Monitor platelet count closely
- Do not exchange with heparin or other LMWHs
- Pregnant women with mechanical prosthetic heart valves may be at increased risk of thrombosis and need more frequent monitoring and dose adjustment as needed
- Dose adjustment is required in severe renal impairment (creatinine clearance <30 mL/min)
- Observe low-weight patients for signs of bleeding
🔄 Drug interactions
- Other anticoagulants
- Platelet inhibitors including acetylsalicylic acid and salicylates
- NSAIDs (including ketorolac tromethamine)
- Dipyridamole
- Sulfinpyrazone
- Whenever possible these agents should be discontinued before starting enoxaparin; if coadministration is essential, close clinical and laboratory monitoring is needed
🤰 Pregnancy
Placental transfer of enoxaparin was observed in animal studies. Human data from a retrospective cohort study of 693 live births suggest enoxaparin does not increase the risk of major developmental abnormalities. Pregnant women receiving enoxaparin should be carefully monitored for bleeding or excessive anticoagulation, and use of a shorter-acting anticoagulant should be considered as delivery approaches. Your doctor will decide whether it is appropriate for you.
🍼 Breastfeeding
The label text provided does not include information on breastfeeding. Ask your doctor or pharmacist before using this medicine while breastfeeding.
🧒 Children
Safety and effectiveness in pediatric patients have not been established. Enoxaparin is not approved for use in neonates or infants.
👴 Older adults
Efficacy in patients 65 years and older was similar to younger patients. Bleeding complications were higher in geriatric patients at doses of 1.5 mg/kg once daily or 1 mg/kg every 12 hours, and the risk of bleeding and serious adverse events increased with age. Careful attention to dosing intervals and concomitant medications (especially antiplatelets) is advised, and monitoring should be considered for elderly patients with low body weight (<45 kg) or reduced kidney function.
🌡️ Storage
Store at 20°C to 25°C (68°F to 77°F). Each prefilled syringe is for single use only.
⏰ Missed dose
The label text provided does not give instructions for a missed dose. Contact your doctor or pharmacist for guidance and do not double the dose on your own.
🆘 Overdose
Accidental overdose may lead to hemorrhagic complications. If overdose is suspected, seek emergency medical care immediately. Healthcare professionals can largely neutralize the effect with slow intravenous protamine sulfate, which should be given only where resuscitation facilities are available because of the risk of severe hypotensive and anaphylactoid reactions.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| INHIXA 20 Enoxaparin | JePharm Drug Store | 2 PFS | 18 ₪ |
| CLEXANE 20MG SAFETY LOCK PREFIL SYR ENOXAPARIN SODIUM 20MG | MSS | 2X0.2ML | 20 ₪ |
| INHIXA 40 Enoxaparin | JePharm Drug Store | 2 PFS | 36 ₪ |
| CLEXANE 40MG SAFETY LOCK PREFIL SYR ENOXAPARIN SODIUM 40MG | MSS | 2X0.4ML | 38 ₪ |
| INHIXA 60 Enoxaparin | JePharm Drug Store | 2 PFS | 47 ₪ |
| CLEXANE 60MG SAFETY LOCK PREFIL SYR ENOXAPARIN SODIUM 60MG | MSS | 2X0.6ML | 49 ₪ |
| INHIXA 80 Enoxaparin | JePharm Drug Store | 2 PFS | 56 ₪ |
| CLEXANE 80MG SAFETY LOCK PREFIL SYR ENOXAPARIN SODIUM 80MG | MSS | 2X0.8ML | 58 ₪ |
| ENOXAPARIN LEDRAXEN 2000 IU (20MG)/0.2ML SYRINGE 10 PFS enoxaparin sodium | True med | 10 PFS | 90 ₪ |
| ENOXAPARIN LEDRAXEN 4000 IU (40MG)/0.4ML SYRINGE 10 PFS enoxaparin sodium | True med | 10 PFS | 180 ₪ |
| ENOXAPARIN LEDRAXEN 6000 IU (60MG)/0.6ML SYRINGE 10 PFS enoxaparin sodium | True med | 10 PFS | 235 ₪ |
| ENOXAPARIN LEDRAXEN 8000 IU (80MG)/0.8ML SYRINGE 10 PFS enoxaparin sodium | True med | 10 PFS | 280 ₪ |
| ENOXAPARIN LEDRAXEN 10000 IU (100MG)/1ML SYRINGE 10 PFS enoxaparin sodium | True med | 10 PFS | 330 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Enoxaparin is a low molecular weight heparin with antithrombotic properties. It has a higher anti-Factor Xa to anti-Factor IIa ratio (mean 14.0 ± 3.1 after 1.5 mg/kg SC) than heparin (1.22 ± 0.13). Peak activity occurs 3 to 5 hours after subcutaneous injection, with absolute bioavailability of approximately 100%.
Labeled dosing
General adult dosing per label (final dose set by the physician): abdominal surgery 40 mg SC once daily (first dose 2 hours before surgery) for 7-10 days; hip or knee replacement 30 mg every 12 hours (first dose 12-24 hours postoperatively once hemostasis is established) for 7-10 days, with 40 mg once daily considered for hip replacement for up to 3 weeks (first dose 12 ±3 hours before surgery); medical patients 40 mg once daily for 6-11 days; DVT treatment 1 mg/kg every 12 hours (outpatient or inpatient) or 1.5 mg/kg once daily (inpatient), with warfarin started usually within 72 hours and enoxaparin continued for at least 5 days until INR 2 to 3; unstable angina/non-Q-wave MI 1 mg/kg every 12 hours with oral aspirin 100-325 mg daily for at least 2 days until clinical stabilization (usually 2-8 days); STEMI 30 mg IV bolus plus 1 mg/kg SC, then 1 mg/kg SC every 12 hours. Adjust dose for creatinine clearance <30 mL/min; for patients ≥75 years in STEMI, omit the IV bolus and use 0.75 mg/kg SC every 12 hours.
- Evaluate for bleeding disorders before starting unless treatment is urgent
- Delay epidural catheter placement or removal at least 12 hours after lower doses (30 mg once or twice daily or 40 mg once daily) and at least 24 hours after higher doses (0.75 mg/kg twice daily, 1 mg/kg twice daily, or 1.5 mg/kg once daily); this does not guarantee neuraxial hematoma will be avoided
- Monitor platelet counts; do not interchange with heparin or other LMWHs
- Most common adverse reactions (>1%): bleeding, anemia, thrombocytopenia, elevated aminotransferases, diarrhea, nausea, ecchymosis, fever, edema, dyspnea, confusion, injection site pain
- Overdose: slow IV protamine sulfate (1% solution), 1 mg per 1 mg enoxaparin if given within the previous 8 hours, or 0.5 mg per 1 mg if more than 8 hours earlier; anti-Factor Xa activity is never completely neutralized (maximum about 60%)
- History of HIT within the past 100 days is a contraindication
🎓 Key points for students
- Enoxaparin: a subcutaneous low molecular weight heparin (LMWH) with a high anti-Xa to anti-IIa ratio
- Key boxed warning: spinal/epidural hematomas with neuraxial anesthesia or spinal puncture
- Typical prophylactic dose is 40 mg once daily; treatment dose is 1 mg/kg every 12 hours
- Overdose is reversed with protamine sulfate, though anti-Xa activity is never completely neutralized (maximum about 60%)
- Contraindications: active major bleeding, history of HIT within 100 days, hypersensitivity to enoxaparin, heparin, or pork products
- Main interacting drugs: other anticoagulants, platelet inhibitors, and NSAIDs
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is enoxaparin and what is it used for?
It is a low molecular weight heparin anticoagulant used to prevent and treat deep vein thrombosis and in certain cases of unstable angina and myocardial infarction (together with aspirin).
How is this medicine given?
It is usually injected under the skin (an initial intravenous dose is also used in STEMI). The dose and duration are set by your doctor or pharmacist for your condition.
Which side effects need urgent medical attention?
Any unusual bleeding, weakness or numbness in the legs (especially after spinal or epidural anesthesia), signs of a severe allergic reaction, or a marked drop in platelets. Seek emergency care right away if these occur.
Can I take it with aspirin or pain relievers?
Aspirin and NSAIDs can increase bleeding risk. They should only be combined with enoxaparin under your doctor's supervision with close monitoring.
Is it safe during pregnancy?
Limited human data suggest it does not increase the risk of major birth defects, but pregnant women need careful monitoring for bleeding. Your doctor will decide if it is right for you.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-09), simplified. Updated: 2026-11-15.